-
Through next-generation alcohol detection technology, we enable trust and empower recovery... with a human touch.
-
SOBRsafe’s advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user’s skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides next generation, passive detection technology for both behavioral health providers and individual consumers.
BEHAVIORAL HEALTH

What if you could check your clients in and screen for alcohol in just 10 seconds?
PERSONAL

What if you or a loved one could easily and discretely prove sobriety, from anywhere?
JUDICIAL

What if you could verify ID and alcohol status 4x faster, or even automate screening?
COMMERCIAL

What if you could demonstrate to insurers a 100% alcohol-free workplace and fleet?
Featured News
SOBRsafe Releases Real-Time Alcohol Detection Wristband with Premium Updates
Featured Case Study
Oceanfront Recovery implements SOBRcheck™ for outpatient monitoring
SOBRsafe Technology: How it Works

What is Transdermal Detection?
- The basic transdermal functionality has been validated by over 8o years of research – this is not new science (just an advanced approach).
- As opposed to invasive testing like breath or blood, transdermal technologies detect alcohol through passive contact with the skin.
- As humans process alcohol, a measurable amount gets released through our pores.
- Transdermal, or touch-based, solutions can identify the presence of alcohol (“pass/fail”) for use in zero tolerance applications, as in alcohol recovery, family law or teen driver safety.

The SOBRsafe Difference
- Our state-of-the-art transdermal sensor is highly precise, and is “tuned” for early, low alcohol detection – beginning at approximately 20 minutes, versus 45-60 minutes for the leading mandatory ankle monitor.
- We detect the presence of alcohol at least equivalent to breathalyzers, and our technology detects alcohol in the body for longer than both breath and blood.
- Our proprietary software acclimates to the wearer’s environment and calibrates to their individual physiology, ensuring greater accuracy and removing human error.

Proven Technology
- Our sensor received an NIAAA grant award in 2017, and has received significant investment since 2019.
- It has been in commercial use since the 2022 launch of SOBRcheck™ for stationary screening – that device has now reported over 100,000 alcohol-free scans.
- Today, SOBRsafe is supporting more than 1 million device interactions per month.